OKYO Pharma Shares Are Trading Higher After the Company's OK-101 Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease in Its First-in-human Phase 2 Trial
OKYO Pharma 的股價走高，此前該公司的 OK-101 在首次人體 2 期試驗中獲得了對乾眼病多種體徵和症狀的統計學意義